Results 1 to 10 of about 482,170 (194)

Novel Treatments in Refractory Recurrent Pericarditis. [PDF]

open access: yesPharmaceuticals (Basel)
Refractory recurrent pericarditis is a troublesome condition that severely impairs the quality of life of affected patients and significantly increases healthcare spending.
Lazarou E   +7 more
europepmc   +4 more sources

Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2021
Non-steroidal anti-inflammatory drugs and colchicine are the cornerstone treatment for recurrent pericarditis. Corticosteroids are frequently used in patients with recurrent episodes of pericarditis.
Vinay Kumar Thallapally   +3 more
doaj   +2 more sources

Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical Trial. [PDF]

open access: yesJ Am Heart Assoc
Background Recurrent pericarditis may be mediated through inappropriate activation of the NACHT, leucine‐rich repeat, and pyrin domain‐containing protein 3 inflammasome. Pharmaceutically manufactured cannabidiol is an oral formulation that inhibits NACHT,
Luis SA   +14 more
europepmc   +2 more sources

Sex related differences in acute and recurrent pericarditis: A narrative review. [PDF]

open access: yesAm Heart J Plus
Background: Acute and recurrent pericarditis represent significant clinical challenges, with growing evidence suggesting important sex-related differences in their presentation, etiology, and course.
Alanazi N.
europepmc   +2 more sources

US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis

open access: yesJournal of the American Heart Association, 2021
Background Patients with recurrent pericarditis (RP) may develop complications, multiple recurrences, or inadequate treatment response. This study aimed to characterize disease burden and unmet needs in RP.
Mike Roy   +2 more
exaly   +3 more sources

Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent [PDF]

open access: yesLife (Basel), 2023
Idiopathic recurrent pericarditis (IRP) can be the hallmark of an autoinflammatory syndrome with recurrent attacks of chest pain and symptom-free intervals following an acute episode. The recurrence rate may be 35% in the pediatric population, frequently
Cinteza E   +6 more
europepmc   +2 more sources

Comparative Efficacy and Safety of Colchicine and Anti-Interleukin-1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials. [PDF]

open access: yesJ Am Heart Assoc
Background The management of recurrent pericarditis includes colchicine and anti–interleukin‐1 agents, given the limited efficacy and adverse effects of NSAIDs and corticosteroids.
Ehsan M   +8 more
europepmc   +2 more sources

Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis. [PDF]

open access: yesLife (Basel)
Recurrent pericarditis is a problematic clinical condition that impairs the quality of life of the affected patients due to the need for repeated hospital admissions, emergency department visits, and complications from medications, especially ...
Lazarou E   +9 more
europepmc   +2 more sources

Pericarditis as an onset of cancer

open access: yesРациональная фармакотерапия в кардиологии, 2023
Pericarditis is an inflammation of the heart serous membrane of an infectious or non-infectious nature. Secondary pericardial effusion can be one of the few signs of cancer of the lung, pleura or breast in young people, while early treatment of the ...
D. F. Mesitskaya   +4 more
doaj   +1 more source

Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Recurrent pericarditis is characterized by painful flares and inflammation, which negatively impact health‐related quality of life. RHAPSODY (rilonacept inhibition of interleukin‐1 alpha and beta for recurrent pericarditis: a pivotal ...
Antonio Brucato   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy